Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

UK cost-utility analysis of rituximab in patients with rheumatoid arthritis that failed to respond adequately to a biologic disease-modifying antirheumatic drug

PaperCitations, authors & open-access status

UK cost-utility analysis of rituximab in patients with rheumatoid arthritis that failed to respond adequately to a biologic disease-modifying antirheumatic drug is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 58 citations, 2008 year and closed oa status.

58
Citations
2008
Year
closed
OA Status

Related on ScholarIQ

Adrian Kielhorn
Author
Current Medical Research and Opinion
Journal
Rheumatoid Arthritis Research and Therapies
Topic
Rheumatoid Arthritis Research and Therapies
Topic
Spondyloarthritis Studies and Treatments
Topic
Autoimmune and Inflammatory Disorders Research
Topic
470M+ articles · free account